Sequana Medical Competitors and Similar CompaniesClear all

Sequana Medical's competitors and similar companies include Smith & Nephew, Otto Bock HealthCare, Biosense Webster and MED-EL.

	Sequana Medical Sequana Medical is a medical device company developing implantable pump systems to manage fluid balance within the body.	Smith & Nephew Smith & Nephew is a medical technology company.	Otto Bock HealthCare Otto Bock HealthCare is a med tech company.	Biosense Webster Biosense Webster is a company focused on the diagnosis and treatment of cardiac arrhythmias.	MED-EL MED-EL is a company providing hearing loss solutions.
Founding Date	Founding Date 2006	Founding Date 1856	Founding Date 1919	Founding Date 1970	Founding Date 1989
Type	Type Public	Type Public	Type Private	Type Subsidiary	Type Private
Tags	Tags Healthcare medical devices medtech	Tags Healthcare healthtech medical devices medtech	Tags Healthcare medical devices medtech	Tags Healthcare medical devices medtech	Tags Healthcare medical devices medtech
Locations	Locations Gent, BE HQ München, DE Zürich, CH	Locations Watford, GB HQ Buenos Aires, AR Macquarie Park, AU Schwechat, AT Zaventem, BE São Paolo, BR Mississauga, CA see more	Locations Duderstadt, DE HQ Ouled Fayet, DZ Buenos Aires, AR Baulkham Hills, AU Wien, AT Sarajevo, BA see more	Locations Irvine, US HQ	Locations Innsbruck, AT HQ
Employees	Employees 4823% decrease	Employees 17,349	Employees 3,893	Employees 2,9923% decrease	Employees 1,9611% increase
Valuation ($)	Valuation ($) 43.3 m	Valuation ($) 13.4 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) €105k (FY, 2024)	Revenue (est.) $6.2b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods €26k (FY, 2024)	Cost of goods $1.4b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit €562k (FY, 2024)	Gross profit $4.8b (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income (€44.7m) (FY, 2024)	Net income $625m (FY, 2025)	Net income N/A	Net income N/A	Net income N/A